Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 7:6:ojae105.
doi: 10.1093/asjof/ojae105. eCollection 2024.

Tranexamic Acid Application in Facial Aesthetic Surgery: An Umbrella Review

Mohamed Badie Ahmed, Deemah Assami, Dima Nasrallah, Fatima Saoud Al-Mohannadi, Salwa Al-Maraghi, Abdelrahman Badie Ahmed, Abeer Alsherawi
Review

Tranexamic Acid Application in Facial Aesthetic Surgery: An Umbrella Review

Mohamed Badie Ahmed et al. Aesthet Surg J Open Forum. .

Abstract

Tranexamic acid (TXA) is an antifibrinolytic agent that is considered as one of the latest interventions currently being investigated in the field of facial aesthetic surgeries, as it is predicted to be effective in reducing intraoperative and postoperative complications of facial aesthetic surgeries. This review focuses on giving readers a comprehensive overview regarding the use of TXA in facial aesthetic surgeries. In this umbrella review, data were extracted from existing systematic reviews and meta-analysis that focused on the use of TXA in facial aesthetic surgeries. The authors searched PubMed, Embase, and Scopus databases. The data were extracted using a standard format, and the AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews) tool was used to assess the quality of the included reviews. In total, this study included 14 systematic reviews and meta-analyses all of which evaluated the effect of TXA on facial aesthetic surgeries, which included rhinoplasty, septorhinoplasty, rhytidectomy, and blepharoplasty. The majority of the included studies focused on reporting the effect of TXA on blood loss volume (BLV) and duration of surgery (DOS) as well as other postoperative complications. Eleven out of the 12 studies that focused on rhinoplasty showed that TXA used reduced BLV. In addition, in 8 studies that were focusing on DOS, the majority showed a reduction in DOS with TXA use. While in the case of septorhinoplasty, 3 studies revealed that TXA use decreased BLV. Moreover, in the case of rhytidectomy, 3 out of 6 systematic reviews showed reduction in BLV, while 2 reported reductions in DOS. Finally, the authors conclude that the use of TXA is indeed efficient in reducing BLV and DOS, in addition to some of the complications that can occur during or after facial aesthetic surgeries. However, in order to reach a final decision on the implication of the use of TXA in facial aesthetic surgeries, further studies should be established using a standardized protocol in assessing the desired outcomes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The coagulation cascade and the mechanism of action of tranexamic acid.
Figure 2.
Figure 2.
PRISMA flow diagram for the included studies.
Figure 3.
Figure 3.
Quality assessment of the 14 syntheses included.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ng W, Jerath A, Wąsowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47:339–350. doi: 10.5603/AIT.a2015.0011 - DOI - PubMed
    1. Jimenez JJ, Iribarren JL, Lorente L, et al. . Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007;11:R117. doi: 10.1186/cc6173 - DOI - PMC - PubMed
    1. Locketz GD, Lozada KN, Bloom JD. Tranexamic acid in aesthetic facial plastic surgery: a systematic review of evidence, applications, and outcomes. Aesthet Surg J Open Forum. 2020;2:ojaa029. doi: 10.1093/asjof/ojaa029 - DOI - PMC - PubMed
    1. Myles PS, Smith JA, Forbes A, et al. . Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136–148. doi: 10.1056/NEJMoa1606424 - DOI - PubMed
    1. Colomina MJ, Contreras L, Guilabert P, Koo M, M Ndez E, Sabate A. Clinical use of tranexamic acid: evidences and controversies. Braz J Anesthesiol. 2022;72:795–812. doi: 10.1016/j.bjane.2021.08.022 - DOI - PMC - PubMed

LinkOut - more resources